NVLN

Novelion Therapeutics Inc. Common Shares
NVLN

Overview Fund Activity
Delisted

NVLN was delisted on the 8th of October, 2019.

Back to rankings

66 hedge funds and large institutions have $146M invested in Novelion Therapeutics Inc. Common Shares in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 19 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
66
Holders Change
–
Holders Change %
0%
% of All Funds
1.65%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.12%
New
11
Increased
17
Reduced
19
Closed
10
Calls
$252K
Puts
$215K
Net Calls
+$37K
Net Calls Change
-$2.21M

Top Buyers

1
OM
Opaleye Management
Massachusetts
+$7.84M
2
HCM
Highbridge Capital Management
New York
+$6.72M
3
AC
Armistice Capital
New York
+$4.64M
4
Millennium Management
Millennium Management
New York
+$3.52M
5
TLCM
Tiger Legatus Capital Management
New York
+$1.37M

Top Sellers

1
SCM
Scopia Capital Management
New York
-$9.85M
2
KPF
K2 Principal Fund
Ontario, Canada
-$2.36M
3
Renaissance Technologies
Renaissance Technologies
New York
-$1.53M
4
DM
Deerfield Management
New York
-$1.44M
5
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$1.2M
Name Holding Trade Value Shares
Change 		Shares
Change %
BC
1
Broadfin Capital
New York
$20.9M – – –
AC
2
Armistice Capital
New York
$19.9M +$4.64M +432,000 +30%
SCM
3
Stonepine Capital Management
Oregon
$16.8M +$392K +36,453 +2%
SCM
4
Sarissa Capital Management
Connecticut
$11M – – –
HVC
5
Healthcare Value Capital
New Jersey
$8.93M – – –
OM
6
Opaleye Management
Massachusetts
$7.84M +$7.84M +730,000 New
HCM
7
Highbridge Capital Management
New York
$6.72M +$6.72M +625,268 New
KCM
8
Kingstown Capital Management
New York
$6.44M – – –
Fidelity Investments
9
Fidelity Investments
Massachusetts
$6.25M -$342K -31,800 -5%
AA
10
Ancora Advisors
Ohio
$5.43M -$587K -54,702 -10%
TLCM
11
Tiger Legatus Capital Management
New York
$4.81M +$1.37M +127,852 +40%
GGHC
12
Gilder Gagnon Howe & Co
New York
$3.56M +$767K +71,409 +27%
Millennium Management
13
Millennium Management
New York
$3.52M +$3.52M +327,550 New
JAM
14
JW Asset Management
Florida
$3.33M -$150K -13,981 -4%
AG
15
Artal Group
Luxembourg
$2.75M – – –
Renaissance Technologies
16
Renaissance Technologies
New York
$2.04M -$1.53M -142,760 -43%
LCS
17
Levin Capital Strategies
New York
$1.97M -$932K -86,758 -32%
Deutsche Bank
18
Deutsche Bank
Germany
$1.86M +$821K +76,503 +79%
OAM
19
Oxford Asset Management
United Kingdom
$1.24M +$1.24M +115,310 New
Goldman Sachs
20
Goldman Sachs
New York
$1.21M +$20.3K +1,889 +2%
DMK
21
David M. Knott
$1.17M – – –
O
22
OrbiMed
New York
$1.07M – – –
Two Sigma Investments
23
Two Sigma Investments
New York
$709K +$453K +42,192 +177%
Connor, Clark & Lunn Investment Management (CC&L)
24
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$615K -$1.2M -111,906 -66%
Morgan Stanley
25
Morgan Stanley
New York
$604K +$587K +54,743 +3,548%
1
2 3